Hints and tips:
...pick-up in M&A/capital market activity in Banks, Real Estate, Construction Materials & Infrastructure, UK Housebuilding & Construction, Airlines, Logistics, Aerospace & Defense, Telecoms, Internet and Pharmaceuticals...
...are wearing their fishnets and eyeliner to work — and they’re not apologising for expressing themselves (Insider) — The rise and fall of TV’s golden age (Stat Significant / Substack) — Devlin-Macgregor Pharmaceuticals...
...That’d be bad news for Hikma Pharmaceuticals (27.2 per cent). What about board chairs and their deputies?...
A story of cancer scares, secretive short sellers, psychological tape bombs and post-investment stress disorder
...“AI’s role in research and development is expanding, especially in industries like pharmaceuticals, material sciences and energy....
Zantac makers feel the burn
...Shares in Petros Pharmaceuticals, a Nasdaq-listed developer of treatments for erectile dysfunction and penile deformity, are suspended up 230 per cent on apparently fake news that it’s to be acquired....
...very slick infomercial which is clearly intended to direct people to the company’s own product,” Graham Dutfield, a law professor and author of That High Design of Purest Gold: A Critical History of the Pharmaceutical...
...A potentially bigger opportunity is pharmaceuticals: a pre-IPO investment deck still available on the SpectrumX website says the company “holds licenses for both the UK and EU pharmaceutical application...
...Dechra Pharmaceuticals, the veterinary medicines maker, said the outlook for its financial year ending June was in line with the upper end of management expectations....
...Briefly Platinum refiner Johnson Matthey has agreed to sell its pharmaceutical ingredients division to Altaris Capital Partners, the New York specialist private equity firm, for £325m....
...sales jumped by 28 per cent on constant exchange rates to $9.9bn, approximately matching consensus forecasts, with year-on-year growth reflecting its purchase of US rare disease medicines maker Alexion Pharmaceuticals...
...Briefly Dechra Pharmaceuticals, the veterinarian drugmaker, said trading has remained strong after posting a 21 per cent jump in annual core earnings....
...Dechra Pharmaceuticals, defence group Meggitt and Wm Morrison Supermarkets are all in line for promotion to the FTSE 100 at the next review, which will be framed around closing prices on August 31 and announced...
...Elliott calls for the “crown jewel” franchise to be kept separate and operationally distinct from pharmaceuticals, which is in disagreement with GSK’s plan....
Plus, Olympics sponsors ask for delay and executives should listen to climate activists
...Essential comment before you go Bryce Elder Six years after Bill Winters took over as CEO of Standard Chartered, the bank is still suffering from the same problems....
...Valued at less than 2 times full-year revenue, the stock is a lowly rated outlier among global pharmaceuticals and trails well behind direct rivals such as Camurus of Sweden, maker of opioid injectable Brixadi...
...A: Chicken Run A family-owned business wins the exclusive contract to operate a pharmaceutical production concession....
...The $3.4bn fund is one of the biggest amassed in the pharmaceutical industry and comes at a time when investment is flooding into the sector....
...US pharmaceutical distributor McKesson is exploring a sale of its European business in a move that would reverse its 2014 acquisition of Germany’s Celesio for $8.3bn, Bloomberg reported....
...Essential comment before you go Bryce Elder ITV’s opening price of 124p on Wednesday was identical to the average value in February 2004, the month of its creation via the merger of Carlton with Granada...
...Spirax-Sarco said organic sales growth in the first four months of 2021 was ahead of the overall market thanks in part to “exceptional” demand from the pharmaceutical and biotechnology sector....
...The chief executive of Moderna said he “didn’t lose a minute of sleep” following the US government’s decision to support the suspension of Covid-19 vaccine patents, a move that stunned the pharmaceutical...
...The pharmaceutical companies applied for authorisation to begin vaccinating adolescents last month after trials suggested the inoculations were 100 per cent effective at preventing symptomatic disease among...
International Edition